Literature DB >> 23086855

On the development and validation of QSAR models.

Paola Gramatica1.   

Abstract

The fundamental and more critical steps that are necessary for the development and validation of QSAR models are presented in this chapter as best practices in the field. These procedures are discussed in the context of predictive QSAR modelling that is focused on achieving models of the highest statistical quality and with external predictive power. The most important and most used statistical parameters needed to verify the real performances of QSAR models (of both linear regression and classification) are presented. Special emphasis is placed on the validation of models, both internally and externally, as well as on the need to define model applicability domains, which should be done when models are employed for the prediction of new external compounds.

Mesh:

Year:  2013        PMID: 23086855     DOI: 10.1007/978-1-62703-059-5_21

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  27 in total

1.  Prediction of drug distribution in rat and humans using an artificial neural networks ensemble and a PBPK model.

Authors:  Paulo Paixão; Natália Aniceto; Luís F Gouveia; José A G Morais
Journal:  Pharm Res       Date:  2014-05-28       Impact factor: 4.200

2.  A novel approach for assessment of antitrypanosomal activity of sesquiterpene lactones through additive and non-additive molecular structure parameters.

Authors:  Mohammad Hossein Keshavarz; Zeinab Shirazi; Faezeh Sayehvand
Journal:  Mol Divers       Date:  2022-07-17       Impact factor: 3.364

3.  Green Synthesis of Thiazolidine-2,4-dione Derivatives and Their Lipoxygenase Inhibition Activity With QSAR and Molecular Docking Studies.

Authors:  Melita Lončarić; Ivica Strelec; Valentina Pavić; Vesna Rastija; Maja Karnaš; Maja Molnar
Journal:  Front Chem       Date:  2022-07-05       Impact factor: 5.545

4.  Identification of potent aldose reductase inhibitors as antidiabetic (Anti-hyperglycemic) agents using QSAR based virtual Screening, molecular Docking, MD simulation and MMGBSA approaches.

Authors:  Ravindra L Bakal; Rahul D Jawarkar; J V Manwar; Minal S Jaiswal; Arabinda Ghosh; Ajaykumar Gandhi; Magdi E A Zaki; Sami Al-Hussain; Abdul Samad; Vijay H Masand; Nobendu Mukerjee; Syed Nasir Abbas Bukhari; Praveen Sharma; Israa Lewaa
Journal:  Saudi Pharm J       Date:  2022-04-07       Impact factor: 4.562

5.  Prediction of Combined Sorbent and Catalyst Materials for SE-SMR, Using QSPR and Multitask Learning.

Authors:  Paula Nkulikiyinka; Stuart T Wagland; Vasilije Manovic; Peter T Clough
Journal:  Ind Eng Chem Res       Date:  2022-06-23       Impact factor: 4.326

6.  Ligand-based and structure-based studies to develop predictive models for SARS-CoV-2 main protease inhibitors through the 3d-qsar.com portal.

Authors:  Eleonora Proia; Alessio Ragno; Lorenzo Antonini; Manuela Sabatino; Milan Mladenovič; Roberto Capobianco; Rino Ragno
Journal:  J Comput Aided Mol Des       Date:  2022-06-18       Impact factor: 4.179

7.  Exploring the Prominent and Concealed Inhibitory Features for Cytoplasmic Isoforms of Hsp90 Using QSAR Analysis.

Authors:  Magdi E A Zaki; Sami A Al-Hussain; Syed Nasir Abbas Bukhari; Vijay H Masand; Mithilesh M Rathore; Sumer D Thakur; Vaishali M Patil
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-01

8.  QSAR-derived affinity fingerprints (part 1): fingerprint construction and modeling performance for similarity searching, bioactivity classification and scaffold hopping.

Authors:  C Škuta; I Cortés-Ciriano; W Dehaen; P Kříž; G J P van Westen; I V Tetko; A Bender; D Svozil
Journal:  J Cheminform       Date:  2020-05-29       Impact factor: 5.514

9.  Natural products as leads in schistosome drug discovery.

Authors:  Bruno J Neves; Carolina H Andrade; Pedro V L Cravo
Journal:  Molecules       Date:  2015-01-23       Impact factor: 4.411

10.  In silico Guided Drug Repurposing: Discovery of New Competitive and Non-competitive Inhibitors of Falcipain-2.

Authors:  Lucas N Alberca; Sara R Chuguransky; Cora L Álvarez; Alan Talevi; Emir Salas-Sarduy
Journal:  Front Chem       Date:  2019-08-06       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.